126 related articles for article (PubMed ID: 1698318)
1. Monoclonal antibodies detecting discrete epitopes of human perforin.
Geisberg M; Trapani JA; Dupont B
Tissue Antigens; 1990 May; 35(5):229-33. PubMed ID: 1698318
[TBL] [Abstract][Full Text] [Related]
2. Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells.
Kawasaki A; Shinkai Y; Kuwana Y; Furuya A; Iigo Y; Hanai N; Itoh S; Yagita H; Okumura K
Int Immunol; 1990; 2(7):677-84. PubMed ID: 2278998
[TBL] [Abstract][Full Text] [Related]
3. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
Hommel-Berrey G; Bochan M; Brahmi Z
Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody.
Hameed A; Olsen KJ; Cheng L; Fox WM; Hruban RH; Podack ER
Am J Pathol; 1992 May; 140(5):1025-30. PubMed ID: 1374586
[TBL] [Abstract][Full Text] [Related]
5. In vivo expression of perforin by CD8+ lymphocytes during an acute viral infection.
Young LH; Klavinskis LS; Oldstone MB; Young JD
J Exp Med; 1989 Jun; 169(6):2159-71. PubMed ID: 2471775
[TBL] [Abstract][Full Text] [Related]
6. The distribution of perforin in normal tissues.
Joag SV; Zheng LM; Persechini P; Michl J; Parr E; Young JD
Immunol Lett; 1991 Jun; 28(3):195-9. PubMed ID: 1885216
[TBL] [Abstract][Full Text] [Related]
7. Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.
Liu CC; Jiang S; Persechini PM; Zychlinsky A; Kaufmann Y; Young JD
J Exp Med; 1989 Jun; 169(6):2211-25. PubMed ID: 2786549
[TBL] [Abstract][Full Text] [Related]
8. Detection of human perforin by ELISpot and ELISA: ex vivo identification of virus-specific cells.
Zuber B; Levitsky V; Jönsson G; Paulie S; Samarina A; Grundström S; Metkar S; Norell H; Callender GG; Froelich C; Ahlborg N
J Immunol Methods; 2005 Jul; 302(1-2):13-25. PubMed ID: 16005014
[TBL] [Abstract][Full Text] [Related]
9. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
Jiang S; Persechini PM; Perussia B; Young JD
J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
[TBL] [Abstract][Full Text] [Related]
10. Analysis of rat natural killer cytotoxic factor (NKCF): mechanism of action and relationship to other cytotoxic/cytostatic factors.
Winkler-Pickett RT; Young HA; Kuta A; Ortaldo JR
Cell Immunol; 1991 Jun; 135(1):42-54. PubMed ID: 2018982
[TBL] [Abstract][Full Text] [Related]
11. Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9.
Lowrey DM; Aebischer T; Olsen K; Lichtenheld M; Rupp F; Hengartner H; Podack ER
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):247-51. PubMed ID: 2783486
[TBL] [Abstract][Full Text] [Related]
12. In vivo expression of perforin by natural killer cells during a viral infection. Studies on uveitis produced by herpes simplex virus type I.
Young LH; Foster CS; Young JD
Am J Pathol; 1990 May; 136(5):1021-30. PubMed ID: 2190470
[TBL] [Abstract][Full Text] [Related]
13. Killing of cells by perforin. Resistance to killing is not due to diminished binding of perforin to the cell membrane.
Jones J; Morgan BP
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):199-204. PubMed ID: 1741748
[TBL] [Abstract][Full Text] [Related]
14. Perforin-mediated myocardial damage in acute myocarditis.
Young LH; Joag SV; Zheng LM; Lee CP; Lee YS; Young JD
Lancet; 1990 Oct; 336(8722):1019-21. PubMed ID: 1699101
[TBL] [Abstract][Full Text] [Related]
15. Cellular localization of perforin 1 in murine cloned cytotoxic T lymphocytes.
Groscurth P; Qiao BY; Podack ER; Hengartner H
J Immunol; 1987 May; 138(9):2749-52. PubMed ID: 3494768
[TBL] [Abstract][Full Text] [Related]
16. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
Kessler B; Hudrisier D; Schroeter M; Tschopp J; Cerottini JC; Luescher IF
J Immunol; 1998 Dec; 161(12):6939-46. PubMed ID: 9862728
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel monoclonal antibody against human perforin using transfected cell lines.
Schlesinger BC; Cheng L
Immunology; 1994 Feb; 81(2):291-5. PubMed ID: 8157278
[TBL] [Abstract][Full Text] [Related]
18. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
Young JD; Jiang S; Liu CC; Hasselkus-Light CS
J Immunol Methods; 1990 Mar; 128(1):133-42. PubMed ID: 1691232
[TBL] [Abstract][Full Text] [Related]
19. Use of the 5'-flanking region of the mouse perforin gene to express human Fc gamma receptor I in cytotoxic T lymphocytes.
Smyth MJ; Kershaw MH; Hulett MD; McKenzie IF; Trapani JA
J Leukoc Biol; 1994 Apr; 55(4):514-22. PubMed ID: 8145022
[TBL] [Abstract][Full Text] [Related]
20. A central role of perforin in cytolysis?
Podack ER; Hengartner H; Lichtenheld MG
Annu Rev Immunol; 1991; 9():129-57. PubMed ID: 1910674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
